Login to Your Account

ECCMID Roundup

Tuesday, May 10, 2011
Inhibitex Inc., of Atlanta, said partner Pfizer Inc. presented Phase I data showing SA3Ag, a three-antigen Staphylococcus aureus vaccine, elicited a positive immune response to each of the three components.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription